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Background: The number of people with a chronic disease will strongly increase in the next decades. Therefore,
prevention of disease becomes increasingly important. The aim of this systematic review was to identify factors that
negatively influence participation in population-based disease prevention programs in General Practice and to
establish whether the program type is related to non-participation levels.
Methods: We conducted a systematic review in Pubmed, EMBASE, CINAHL and PsycINFO, covering 2000 through
July 6th 2012, to identify publications including information about characteristics of non-participants or reasons for
non-participation in population-based disease prevention programs in General Practice.
Results: A total of 24 original studies met our criteria, seven of which focused on vaccination, eleven on screening
aimed at early detection of disease, and six on screening aimed at identifying high risk of a disease, targeting a
variety of diseases and conditions. Lack of personal relevance of the program, younger age, higher social
deprivation and former non-participation were related to actual non-participation. No differences were found in
non-participation levels or factors related to non-participation between the three program types. The large variation
in non-participation levels within the program types may be partly due to differences in recruitment strategies, with
more active, personalized strategies resulting in higher participation levels compared to an invitation letter.
Conclusions: There is still much to be gained by tailoring strategies to improve participation in those who are less
likely to do so, namely younger individuals, those living in a deprived area and former non-participants.
Participation may increase by applying more active recruitment strategies.
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The number of people with a chronic disease will
strongly increase in the next decades. For example, the
worldwide prevalence of diabetes mellitus, is expected to
increase by 54% from 2010 to 2030 [1]. Chronic diseases
are responsible for a considerable burden to both the
individual and to the healthcare system. Consequently,
it is expected that the demand on health care will rise
excessively, and preservation of good quality healthcare
becomes unaffordable.
In order to reduce the disease burden for people and
to keep healthcare affordable, a shift from treatment of
an individual with a disease towards maintenance of
health or postponement of disease, becomes inevitable.* Correspondence: b.koopmans@nivel.nl
Netherlands Institute for Health Services Research, Utrecht, The Netherlands
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distribution, and reproduction in any mediumGeneral Practitioners (GPs) play an important role in
prevention, since they deliver comprehensive, holistic
and easily accessible care. GPs generally provide pre-
ventive care in the individual setting of a consultation,
either on the indication of present risk factors and
symptoms of disease or care-related, for example to
reduce the risk of complications of chronic disease.
Population-based prevention has a less prominent role
in General Practice [2]. Population-based prevention
programs initiated by GPs potentially contribute signifi-
cantly to reduce the risk of developing chronic diseases
or to identify treatable diseases at an early stage (disease
prevention).
Current examples of population-based disease preven-
tion programs embedded in General Practice include
vaccination programs (e.g. vaccination for influenza) and
screening programs (e.g. screening for cervical cancer).tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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eases or to diminish the impact of infectious diseases.
Population-based screening aims at early detection of
a disease, thereby increasing the chance of successful
treatment and diminishing the impact of the disease, or
it intends to identify persons with a high risk of develop-
ing a chronic condition, whereby changes in lifestyle
and/or use of medication could reduce this risk substan-
tially. Prevention programs embedded in General Prac-
tice practices are usually applied in individuals with a
potential elevated risk of disease, since this is thought to
be the most (cost) effective approach [3]; only those who
might benefit most are invited, whereas the number of
those who undergo clinical measurements is minimized.
Furthermore, in this manner workload in General Prac-
tice is limited.
The potential gains of prevention in persons with an
elevated risk of disease are considerable, yet the chal-
lenges in changing health risks are numerous. Health
benefits of the total population increase by increasing
participation levels of high risk individuals. However,
participation levels are often suboptimal and differ
between groups. To increase this level, it is important to
know which individuals are less likely to participate and
to understand their reasons and barriers. Previous stud-
ies showed that numerous socio-demographic and
behavioural factors may play a role, as well as factors on
a community or organizational level [4-8]. In addition,
factors, such as the nature of the target condition [9]
and the program itself [6], may also play a role in the
willingness to participate. Finally, the method of recruit-
ment might influence the participation level as well [6].
The aim of this systematic review is to identify factors
that negatively influence participation in population-
based disease prevention programs in General Practice
and to establish whether the program type is related to
participation levels.
Methods
Data sources and searches
A systematic literature search was conducted in
Pubmed, EMBASE, CINAHL and PsycINFO to identify
relevant articles published between January 1st, 2000 and
July 6th, 2012. Language was restricted to English and
Dutch. The search strategy was formulated in Pubmed
and adapted to the other databases (see Additional file1:
Appendix 1 for the search strategy). When necessary,
equivalents for the MeSH terms were used or MeSH
terms were used as free text words.
Study selection
The first two stages of the selection for inclusion; in suc-
cession, the screening of titles, and abstracts, were per-
formed by the first author (BK). JK also screened arandom 10% of the abstracts and interrater agreement
was high (kappa 0.89). All articles were screened on full
text by two authors according to the criteria presented
in Additional file 2: Box 1.
We aimed to select articles including information on
non-participation in population-based disease preven-
tion programs aimed at high-risk individuals in General
Practice. This type of programs include an active
approach of inviting a pre-defined target group to
undergo screening or vaccination.
The most important inclusion criteria were:
– Programs had to be population based, and therefore
not related to the individual care setting
(e.g. opportunistic screening following complaints of
the patient), and
– aimed at high risk individuals.
– Programs needed to be performed in General
Practice.
– Studies needed to give information on either
characteristics or reasons of non-participation
or both.
Furthermore, to be included, articles had to describe
original studies.
BK screened all articles, JK and MN screened each half
of the articles. Disagreements were solved by the authors
who screened the article, in case of no consensus, the
third reviewer was consulted and the majority decided.
Data extraction
For each study, the following data were abstracted:
1. general information: first author, year of publication,
design, sample size and country where the study was
conducted.
2. general information of the program: target disease,
inclusion criteria of the target group, recruitment
strategy, sending of reminders, variables used to
compare participants and non-participants.
3. information on participation levels and willingness to
participate.
For reasons of efficiency, only the significant differ-
ences between non-participants and participants were
mentioned in the results section. In addition, results
were presented in a narrative summary of characteristics
that negatively influence participation, rather than in
terms of effect sizes.
Data synthesis
Studies were grouped based on the goal of the program
(program type): 1) vaccination, 2) early detection of
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Furthermore, to avoid duplicate presentation of the same
data we grouped studies within the same population.
Non-participation levels, significant characteristics of
non-participants and their reasons when mentioned in
both studies were only presented once, using the results
of the study including the largest sample size within the
same population.
Assessment of study quality
Existing quality assessment instruments mainly focus on
the quality around the primary outcome, rather than to
secondary issues as is the case in our review. Therefore,
we assessed quality of the studies based on the presence
(or absence) of our main inclusion criterion. Studies not
including characteristics or reasons of non-participants
were found of insufficient quality and therefore excluded.
Studies including characteristics or reasons of non-
participants were found of moderate quality and received
one asterisk, studies including both characteristics AND
reasons of non-participants were found of higher quality
and received two asterisks.
Results
The database search yielded 6,706 articles in total of
which 4,436 remained after eliminating duplicates (see
Figure 1). From the 148 articles selected on the basis ofTotal: 6
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Figure 1 Flow diagram outlining the study selection process. * performtitle and abstract, 30 articles were eligible for this review,
based on the criteria as shown in Box 1.
Two of these articles [10,11] were excluded because of
double publication of part of the results of the same
large study, which were presented all together in one
other article [12], leaving 28 articles for inclusion. Two
of the included articles [13,14] were conducted in the
same study population but with other study aims, and
three studies [15-17] were performed in a subpopulation
of a large study [18-20]. Therefore, this review includes
studies in 24 original populations. Reasons to exclude
articles after screening of the full text were lack of infor-
mation about non-participation (58%), prevention pro-
gram was not initiated by GPs or no separate data of the
General Practice setting was presented (17%), or because
the program was not a population-based prevention
program (13%).
Study characteristics
Seven of the 24 original studies described vaccination
programs (five targeting influenza (described in six stud-
ies) [17,18,21-24], one Herpes zoster [25] and one
Pneumococcal bacteraemia [26]), and eleven described
screening programs aimed at early detection of disease
(cervical cancer [27,28], Chlamydia [12,29], diabetes mel-
litus (described in seven studies) [9,13-16,19,20], depres-
sion [30,31], and dementia [32]). Six studies described,706
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risk of a disease and were focused on cardio-metabolic
risk [33-35], diabetes mellitus [36], fractures [37], and
risk drinking [38] (Table 1). In the six studies aimed
at the identification of high risk of disease, also lifestyle
advice [36] treatment [37,38] or a combination of both
[33,35] was offered.
Study quality is presented in Table 1. Twenty original
studies were qualified as ‘moderate’ [9,13-20,22-34,37,38].
Of these studies, one assessed reasons of non-participation
[23]. Four studies were of ‘higher’ quality [12,21,35,36].
No differences were found in levels of non-participation
between studies of moderate and higher quality.Recruitment strategies
Recruitment of the target group was performed by send-
ing a letter on behalf of the GP in 17 studies (71%), in
three studies individuals of the target group were invited
in the practice prior to their consultation, regardless
their complaints [29,31]. In one study the target group
was partly invited by telephone [34] and in another
study by using posters and leaflets in the waiting
room [35]. In six studies participation levels were com-
pared using different recruitment strategies, namely an
informed choice versus a standard letter, vaccination at
the clinic versus a health check plus vaccination at
home, an invitation letter versus posters and leaflets in
the waiting room, using telephone recruitment and
booking, and loss framed versus gain framed messages
(information on screening aimed at what people may
lose by not participating versus what they may gain by
participating) [9,14,22,23,34,35].Non-participation in population-based disease
prevention programs
In general, non-participation levels showed a very broad
range from 10% to 99% (median 38%) (see Table 1). Not
only between studies targeting different diseases, but
also within studies targeting the same disease, differ-
ences in non-participation levels were high.
Table 2 summarizes the significant socio-demographics
and behavioural factors related to non-participation.
Behavioural factors were significantly related to non-
participation in all of the studies they were accounted for
[13,22,24,25,28,32]. Several behavioural factors indicated
an underestimation of the personal importance to par-
ticipate, which was also the most cited reason of non-
participation [12,21,23,31,36], followed by being unable
to attend or hold on to the program [21,23,31,36], con-
cerns about side effects [21,23], and unpleasantness
of vaccination/screening [12,21] (data not shown). In
addition, former non-participation was an indication of
actual non-participation as well [22,24].Less evidence was found for socio-demographic factors
to play a role in non-participation. Age, sex and socioe-
conomic status (SES) were significantly related to non-
participation in respectively 75%, 53% and 50% of the
studies, but the effects of these factors remained unclear
since results contradicted. However, non-participants
are likely to be younger (in 11 out of 15 studies)
[9,19,20,30,33,36-38] and male (in 6 out of 9 studies)
[12,19,20,30,33,36]. Furthermore, there was some indica-
tion that non-participants were more likely to be living
in deprived area’s [9,12,18,20] and to have a lower health
consumption [9,13,20,33] (data not shown).
Health status, which was operationalized in various
ways (e.g. presence of unhealthy lifestyle factors or
chronic disease and self-reported health) was in both
positively and negatively related to participation in an
equal way. Only a few studies included physical environ-
ment and practice related factors and the effect of these
factors therefore remains unclear.
More detailed information per study of factors included
and factors significantly related to non-participation is
presented in Additional file 3: Appendix 2.
Related to recruitment strategy, non-participation levels
within comparable programs were lower in studies in
which a more active recruitment strategy was used to
improve uptake, including vaccination at home [22],
telephone recruitment and booking [23], and recruitment
in the practice compared to studies in which a personal
invitation by letter was used [29,31]. Also, offering a
paper [33] instead of an on-line risk questionnaire [35]
resulted in higher uptake in comparable programs.
Furthermore, a more passive recruitment strategy
(posters and leaflets in the waiting room) resulted in
a much higher non-participation level compared to an
invitation letter in the same study [35].
No clear difference could be found between the pro-
gram types with respect to non-participation levels. They
all showed a similar very broad range in non-
participation levels (vaccination: 17% to 88% (median
32%), early detection: 10% to 65% (median 27%), and
identification of high risk: 25% to 99% (median 52%))
(see Table 1). Furthermore, no indication was found
of differences between the three program types with
respect to factors related to non-participation.
Discussion
To our knowledge, this is the first review on non-
participation in vaccination programs as well as population-
based screening programs embedded in General Practice.
In total, 28 studies in 24 original populations matched
our search criteria regarding three program types: vac-
cination, early detection of disease, and identification of
high risk of a disease. Non-participation levels ranged be-
tween 10% and 99% in all three program types. Median
Table 1 Characteristics and non-participation levels of included studies
First author and year Study design Study size (n) Country Target disease Inclusion criteria
target group
Recruitment
strategy
Non-participation
level
Study
quality#
Vaccination
Allsup [21], 2002 RCT 2583 UK Influenza Age (65–74),
medical record
Letter + reminder 88% * **
Arthur [22], 2002 RCT 2052 UK Influenza Age (≥ 75) Letter health check +
vaccination:
26% vaccination
in clinic: 32%
*
Evans [24], 2003 Observational 2600 UK Influenza Age (≥ 65) Not clear na *
MRC Trial of Assessment
and Management of Older
People in the Community
(MRC Study) Breeze [18],
2004 Mangtani [17],
2005 (sub study)
Observational 28492
5572
UK Influenza Age (≥ 75) Letter 1997: 52% 1998:
50% 1999:
49% 2000: 37%
*
Byrnes [23], 2006 Observational 580 Australia Influenza Age (≥ 65) Telephone+
reminder
2004: 23% 2005:
17%
*
Opstelten [25], 2009 Observational 1778 The Netherlands Herpes zoster
and influenza
Age (≥ 65) Letter + reminder HZ (with and
without influenza):
61%, Influenza
(with and without
HZ): 24%
*
Vila-Córcoles [26], 2006 Observational 10410 Spain Pneumococcal
bacteraemia/
invasive disease
Age (≥ 65) Not clear 2001: 56% 2002:
49% 2003: 48%
*
Screening aimed at early
detection of disease
Moser [27], 2009 Observational 3185 UK Cervical cancer Age (25–64),
female sex
Letter na *
Tacken [28], 2007 Observational 2224 The Netherlands Cervical cancer Age (30–60),
female sex
Letter + reminder na *
Low [12], 2005 Observational 19773 UK Chlamydia Age (16–39) Letter + reminder 65% **
Verhoeven [29], 2004 Observational 339 Belgium Chlamydia Age (18–35),
female sex
In General
Practice practice
15% *
Pilot ADDITION trial UK:
Park [13,14], 2008, 2010
RCT 355 UK Diabetes Age (40–69),
medical record
Letter 18% *
Koopm
ans
et
al.BM
C
Public
H
ealth
2012,12:856
Page
5
of
10
http://w
w
w
.biom
edcentral.com
/1471-2458/12/856
Table 1 Characteristics and non-participation levels of included studies (Continued)
ADDITION trial UK:
Sargeant [20],
2010 Eborall [16],
2007 (sub study)
Observational study
Controlled trial
33539
7380
UK Diabetes Age (40–69),
medical record
Letter + reminder 26% *
ADDITION trial Denmark:
Christensen [19],
2004 Dalsgaard [15],
2009 (sub study)
Observational 60926
4603
Denmark Diabetes Age (40–69),
medical record
Letter 50% *
Marteau [9], 2010 RCT 1272 UK Diabetes Age (40–69),
medical record
Letter 43% *
Van der Veen [30], 2009 Observational 8475 The Netherlands Depression and
anxiety
Age (18–65),
recent contact PCP,
medical record
Letter 64% *
Yeung [31], 2006 Observational 5203 USA Depression Age (≥ 18),
ethnicity
In General
Practice practice
27% *
Fowler [32], 2012 Observational 554 USA Dementia Age (≥ 65),
medical record
In General
Practice practice
10% *
Screening aimed at
identification of high risk
of disease
Vermunt [36], 2010 Observational 16032 The Netherlands Diabetes Age (40–70),
medical record
Letter 45% **
Van de Kerkhof [33], 2010 Observational 1704 The Netherlands Cardio-metabolic
risk
Age (40–75),
medical record
Letter 25% *
Nielen [35], 2011 Observational 9896 ** The Netherlands Cardio-metabolic
risk
Age (45–70),
medical record
Letter or poster
and leaflets in
waiting room
Letter: 67%
Poster/leaflet:
99%
**
Lambert [34], 2011 Observational 24166 UK Cardio-metabolic
risk
Age (≥ 40),
male sex,
medical record
Letter or
telephone call
76% *
Barr [37], 2005 Observational 5306 UK Fractures Age (≥ 70),
female sex
Letter 32% *
Zanjani [38], 2006 Observational 8367 USA Risk drinking Age (≥ 65) Not clear 52% *
na : not applicable.
* : low participation level mainly due to the research design; randomized controlled trial of vaccination versus placebo.
HZ: Herpes Zoster.
**: in one half of the practices, GPs invited their selected patients by mail (n = 1583) and in the other half of the practices patients were invited by posters and leaflets in the waiting room (n = 8313 patients belonging
to the target group).
#: study quality. * = characteristics or reasons of non-participants given, ** = characteristics and reasons of non-participants given.
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Table 2 Summary of significant socio-demographics and behavioural factors related to non-participation
Factor (n studies used) # N studies
stat. sig. (%)
Non-participation
vaccination
Non-participation early
detection of disease
Non-participation
identification high risk
of a disease
Age (20) [9,12-14,18-20,22,
24-26,28-33,35-38]
15 (75%) Younger [24,26] Older [18] Younger [9,12,19,20,29,30]
Youngest and oldest [28]
Older [32]
Younger [33,36,38]
Older [37]
Sex (17) [9,12-14,18-22,24-26,
30-33,35,36,38]
9 (53%) Female [18,21] Male [12,19,20,30] Female [38] Male [33,36]
SES(−related factors) * (8)
[15,18,25,27,28,32,33,35]
4 (50%) Low [18] High [25] Low [15] Low [33]
Behavioural factors (6)
[13,22,24,25,28,32]
6 (100%) Lack of relevance [24] Lack
of net benefit [24,25]
Low perceived severity [25]
Barriers [25] (to much trouble,
being against vaccination)
Previous non-participation
[22,24]
Stronger belief that physician
wants women to attend
screening [28] Less strong
feeling a personal moral
obligation [28] Higher treatment
control [13] Lower negative
emotional perceptions [13]
Lower perceived benefit [32]
SES(−related factors) *: Socioeconomic status (SES), education, employment, income.
# in case of use of a variable in both trial and sub study in the same population, the variable is included only once.
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that program type does not seem to influence non-
participation in population-based disease prevention pro-
grams in General Practice. In addition, no differences
were found between the three program types with
respect to factors related to non-participation. However,
within each program type, and even within programs
targeting the same disease, considerable differences were
shown, which may be partly related to differences in
recruitment strategies used.
Three groups were identified which might need spe-
cific attention, since they are less likely to participate in
population-based disease prevention programs in Gen-
eral Practice; younger individuals, the people living in a
socially deprived area, and former non-participants. In
general, non-participants found participation not to be
of personal relevance.
A previous review on vaccination programs also
showed younger individuals to be less likely to partici-
pate, however, screening studies showed ambiguous out-
comes of age [6,7]. Living in socially deprived area was
also shown to be related to non-participation in vaccin-
ation programs [4] as well as in colorectal and cervical
cancer screening [39,40]. Previous non-participation,
either in the same or other programs is a strong pre-
dictor of current non-participation [6], which was also
reflected in the lower likelihood of non-participation in
individuals with a higher health care consumption in the
diabetes screening programs [13,20]. An explanation
could be that people get familiar with the tests and pro-
cedures involved and overcome their barriers.
Lack of personal relevance and low perceived risk are
important factors in non-participation [7,41,42]. People
may not respond since they feel and think they livehealthy [4]. However, risk of disease is also a difficult
concept for people to understand and often underesti-
mated, especially in diseases that may be preventable by
behavioural change [43].
The lowest non-participation levels were seen in pro-
grams applying more active and personal approaches,
including recruitment in General Practice. A passive
approach including recruitment by posters and leaflets
in the waiting room of the General Practice practice,
resulted in only little participation [35]. Personal contact
with a GP or nurse therefore seems to play a decisive
role in increasing participation [7]. Two other reviews
showed that invitation, reminding, and counselling by
telephone all seem to be effective interventions to
increase uptake, however, they are much more intensive
and expensive [6,44]. Furthermore, the results of this
review indicate that it might be important to more spe-
cifically address to the personal relevance of vaccination
and screening. Recent studies showed that the concept
of risk is better understood if information is presented
in terms of natural frequencies rather than as an abso-
lute or relative risk [45]. In addition, low future time
orientation, as often seen in the socially deprived, may
be addressed to, since this is associated with a lower
likeliness of changing (health) behaviour. Invitations
should therefore stress the immediate benefits and
remove barriers to e.g. participate in vaccination or
screening and/or changing lifestyle [8,46].
Noticeably, relatively few programs were aimed at
identification of high risk of disease. For example, only
one out of eight of programs focused on diabetes was
aimed at identifying high risk of this disease. The rela-
tively low participation level in this study may have been
due to the fact that the invitation letter informed
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they would be offered a lifestyle intervention. The pro-
spect of having to change ones lifestyle may have dis-
couraged some people to participate [36].
Our inclusion criteria are mainly related to health care
systems in which the GP is a gatekeeper, which is the
case in the Netherlands. Within this system GPs are able
to pro-actively invite potentially high risk individuals
within their patient population. This is reflected in the
studies presented in this review. In countries with a
non-gatekeeper system, the described programs would
be performed in an opportunistic manner, which was an
exclusion criteria in this review. Furthermore, population-
based prevention programs in Europe are generally free
of charge, while individuals in the USA have to pay or get
reimbursement through their insurance. Generalizability
of the results of this review, therefore, may be limited.
Some limitations of this systematic review can be
noted. First, as with systematic reviews in general, des-
pite of a thorough search strategy, relevant (un)published
studies may have been omitted, as well as non-English
or Dutch articles. Adding the concept ‘feasibility’ to the
search strategy may have resulted in more included stud-
ies. Additionally, research on breast- and colon cancer
screening was not retrieved since these programs need
more specific equipment, which is usually not available
in General Practice practices. Furthermore, although par-
ticipation may have been studied, the results may not
have been included in the final article. Next, the rela-
tively small number of studies included, and the large
heterogeneity in study characteristics and results require
cautious interpretation of the results of this review.
Additionally, six included studies were part of the
same international trial. Therefore, although we tried
carefully to prevent presentation of duplicate data some
bias may have been introduced. However, in the UK and
Denmark arm of the study different target groups and
recruitment strategies were used. In addition, the major-
ity of the included studies were trials instead of real-
world programs. This may have led to an overestimation
of the participation levels, since these studies may be
more likely to be performed in well-organized General
Practice practices in less deprived areas. Finally, although
we identified some factors that might be related to non-
participation, it remains unclear from this review how
these factors interrelate.
The findings of our systematic review provide guid-
ance for future research and General Practice. Only 17%
of the studies addressed both characteristics and reasons
of non-participation. To gain more insight in who is not
willing to participate in disease prevention programs and
why, it is important to assess both.
Future research on willingness to participate should
focus on programs aimed at identifying high risk ofdisease, since they may have great potential in improv-
ing population health but are also more demanding to
people than the other two types. Additionally, research
should be focused on the consequences this may have
for recruitment in these programs.
Recruitment strategies should address to personal rele-
vance, and to be tailored to the specific needs of sub-
groups of individuals. Those who are less likely to
participate, such as individuals living in a deprived area,
former non-participants and younger individuals, may
need to be more actively recruited, in which contact
with a health professional may be pivotal, especially
when invited for the first time. For example, GPs and
practice nurses may emphasize the importance of par-
ticipation during regular encounters. In those who are
more likely to engage in vaccination and/or screening,
an invitation letter signed by the GP may be sufficient.Conclusion
In conclusion, in this review we did not find clear
evidence of program type influencing non-participation
in population-based disease prevention programs. In
general, conflicting results regarding factors related to
non-participation were shown, yet we did find three
groups that might be less likely to participate, namely
younger individuals, those living in a deprived area and
former non-participants. Furthermore, higher participa-
tion levels were reached in studies with more active
recruitment strategies. Therefore, there is still much to
be gained by tailoring strategies to improve participation
in those who are less likely to do so.Additional files
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Additional file 3: Appendix 2. Detailed information of studies of
vaccination programs and screening programs aimed at early detection
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